fluorescent dyes
Autoimmune Disease Diagnostic Firm Exagen Raises $22.6M
The financing will go toward ongoing commercialization of the firm's autoimmune tests and therapeutics promotion business.
The platform, which its developers said is well suited to point-of-care testing, uses fluorescent polymers to distinguish between samples from cases and controls.
Medite Closes $5.4M Private Financing
The cancer diagnostics firm said the new funding will go toward bringing new cancer diagnostics to market and to pay off debt.